Related Experiment Video
Updated: Jan 17, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
Expression patterns of PIK3CA and PTEN in cancer and type 2 diabetes mellitus
Donovan Ariel Rivero1, Jacqueline Lisset Tomsich2, Paula Agustina Benegas1
1Laboratorio de Biotecnología Molecular, Instituto de Biotecnología Misiones, Facultad de Ciencias Exactas, Químicas y Naturales (FCEQyN), Universidad Nacional de Misiones (UNaM), "Dra. María Ebe Reca", Ruta 12, km 7.5, C.P.: 3300, Miguel Lanús, Posadas, Misiones, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina (CONICET), Buenos Aires, Argentina.
Abstract:
Type 2 diabetes mellitus (T2DM) and cancer share key metabolic and molecular pathways, including the PI3K/PTEN/AKT signaling cascade, which plays a central role in glucose metabolism and cell proliferation. This study aimed to evaluate the expression levels of PIK3CA and PTEN genes in individuals with cancer and T2DM, to explore their potential role in cancer progression among diabetic patients. A total of 115 individuals were categorized into four groups: healthy controls (C, n = 27), patients with T2DM (SD, n = 30), cancer patients (Ca, n = 28), and patients with both cancer and diabetes (CD, n = 30). Gene expression was analyzed by real-time PCR, and biochemical parameters were assessed. Statistical analysis included the Kruskal-Wallis and Spearman correlation tests. The expression of the PIK3CA gene was significantly higher in the Ca group compared to the other groups (p = 0.0435), with 77 % of cancer patients exhibiting overexpression. In contrast, only 37 % of CD patients showed PIK3CA overexpression. The expression of the PTEN gene was significantly lower in the SD and CD groups compared to the Ca group (p < 0.05). No significant differences in PIK3CA expression were observed among different cancer types. These findings suggest that PIK3CA and PTEN may serve as potential peripheral indicators of systemic alterations in the PI3K/PTEN pathway in cancer and T2DM, highlighting the need for further research, including tissue validation and biomarker performance assessment.
Insights
This study found altered PIK3CA and PTEN gene expression in patients with type 2 diabetes mellitus (T2DM) and cancer. These gene expression changes may indicate systemic pathway alterations, suggesting potential roles in disease progression.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Type 2 diabetes mellitus (T2DM) and cancer share common metabolic pathways, notably the PI3K/PTEN/AKT signaling cascade.
- This pathway is crucial for regulating glucose metabolism and cell proliferation, linking T2DM and cancer development.
Purpose of the Study:
- To investigate the expression levels of PIK3CA and PTEN genes in individuals with cancer and T2DM.
- To explore the potential role of these genes in cancer progression within the context of diabetes.
Main Methods:
- Gene expression analysis using real-time PCR in 115 participants across four groups: healthy controls, T2DM patients, cancer patients, and patients with both conditions.
- Assessment of biochemical parameters and statistical analysis using Kruskal-Wallis and Spearman correlation tests.
Main Results:
- PIK3CA gene expression was significantly higher in cancer patients (77% overexpression) compared to other groups.
- PTEN gene expression was significantly lower in T2DM and cancer with T2DM groups compared to cancer-only patients.
- No significant differences in PIK3CA expression were found across different cancer types.
Conclusions:
- PIK3CA and PTEN gene expression patterns suggest potential as peripheral indicators of PI3K/PTEN pathway alterations in cancer and T2DM.
- Further research, including tissue validation and biomarker assessment, is warranted to confirm these findings and their clinical implications.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Type 2 and Gestational

